MY170724A - Use of certain trioxygenated benzene derivatives in body fat management - Google Patents

Use of certain trioxygenated benzene derivatives in body fat management

Info

Publication number
MY170724A
MY170724A MYPI2014001278A MYPI2014001278A MY170724A MY 170724 A MY170724 A MY 170724A MY PI2014001278 A MYPI2014001278 A MY PI2014001278A MY PI2014001278 A MYPI2014001278 A MY PI2014001278A MY 170724 A MY170724 A MY 170724A
Authority
MY
Malaysia
Prior art keywords
body fat
certain
trioxygenated
formula
benzene derivatives
Prior art date
Application number
MYPI2014001278A
Inventor
K George Annie George V
Matthias Gehling
Torsten Grothe
Jens Bitzer
Barbel Kopcke
Ingo Wohrle
Sasikala Chinnappan
Akir Mazria Haslina Md
Original Assignee
Biotropics Malaysia Berhad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotropics Malaysia Berhad filed Critical Biotropics Malaysia Berhad
Publication of MY170724A publication Critical patent/MY170724A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]

Abstract

The invention primarily relates to the use of certain trioxygenated benzene derivatives of formula (I) or a corresponding plant extract as body fat modulating agents, preferably as anti-cellulite actives and/or for the reduction of the body fat content, in particular for reduction of body weight and/or for the management of obesity. The present invention also relates to corresponding methods and to certain novel compounds of formula (I). The invention further relates to specific plant extract formulations obtainable from plant roots of Labisia pumila, and to compositions, in particular cosmetic or pharmaceutical formulations, comprising an effective amount of one or more compounds of formula (I) or of a corresponding plant extract formulation.
MYPI2014001278A 2012-01-27 2012-01-27 Use of certain trioxygenated benzene derivatives in body fat management MY170724A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MY2012/000008 WO2013112040A1 (en) 2012-01-27 2012-01-27 Use of certain trioxygenated benzene derivatives in body fat management

Publications (1)

Publication Number Publication Date
MY170724A true MY170724A (en) 2019-08-27

Family

ID=45688211

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2014001278A MY170724A (en) 2012-01-27 2012-01-27 Use of certain trioxygenated benzene derivatives in body fat management

Country Status (2)

Country Link
MY (1) MY170724A (en)
WO (1) WO2013112040A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016093692A1 (en) * 2014-12-08 2016-06-16 Universiti Sains Malaysia Standardised extract of labisia pumila for weight reduction and nanoformulation thereof
CN106562939B (en) * 2015-10-08 2019-01-15 中国科学院微生物研究所 Application of the compound AJ-4 in the drug that preparation treats or prevents influenza virus
MY183077A (en) * 2016-08-01 2021-02-10 Univ Kebangsaan Malaysia A process for extracting irisresorcinol from labisia pumila
US20230134529A1 (en) 2021-11-02 2023-05-04 Medika Natura Sdn. Bhd. Labisia pumila extract composition and its pharmaceutical formulation

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352690A (en) 1992-07-01 1994-10-04 Eli Lilly And Company 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists
ATE245622T1 (en) * 1996-02-02 2003-08-15 Merck & Co Inc ANTIDIABETIC AGENTS
US6530886B1 (en) 1999-10-08 2003-03-11 Tanita Corporation Method and apparatus for measuring subcutaneous fat using ultrasonic wave
DE10009423A1 (en) 2000-02-28 2001-09-06 Henkel Kgaa Cosmetic or pharmaceutical preparation especially for treatment of cellulite comprises nerve fibre stimulator or depolariser, phosphodiesterase inhibitor and antiestrogen
DE50104611D1 (en) 2000-04-12 2004-12-30 Bitop Ag USE OF COMPATIBLE SOLUTES AS SUBSTANCES WITH RADICAL-CATCHING PROPERTIES
US20040028631A1 (en) 2000-08-18 2004-02-12 Thomas Schwarz Cosmetic formulations
EP1234572B1 (en) 2001-02-26 2013-10-30 Mibelle AG Cosmetics Skin treatment compositions containing isoflavone aglycones
DE10254872A1 (en) 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilic acid amides and their derivatives as cosmetic and pharmaceutical active ingredients
KR100572621B1 (en) 2003-03-19 2006-04-24 한국 한의학 연구원 Composition for treatment of obesity and metabolic syndrome
WO2004096252A1 (en) 2003-04-25 2004-11-11 Primavera Biosciences, Inc. Compositions and methods for weight loss
EP1648403B1 (en) 2003-05-20 2012-08-15 Sederma Slimming cosmetic composition comprising cafestol or kahweol
US9987217B2 (en) 2004-06-18 2018-06-05 Symrise Ag Blackberry extract
EP1807039A1 (en) 2004-10-25 2007-07-18 Symrise GmbH & Co. KG Use of glycosylated flavanones for the browning of skin or hair
ATE425732T1 (en) 2004-11-22 2009-04-15 Symrise Gmbh & Co Kg FORMULATIONS CONTAINING CERAMIDS AND/OR PSEUDOCERAMIDS AND (ALPHA-)BISABOLOL FOR THE TREATMENT OF SKIN DAMAGE
NZ555836A (en) 2004-12-14 2009-09-25 Menarini Ricerche Spa Pharmaceutical compositions for the treatment of cellulite
MY147497A (en) 2005-10-12 2012-12-14 Government Of Malaysia As Represented By The Ministry Of Science Technology And Innovation Malaysia Process for preparation of labisia pumila extract
ATE536916T1 (en) 2005-10-14 2011-12-15 Symrise Ag SYNERGISTIC BLENDS OF BISABOLOL AND GINGER EXTRACT
FR2895676B1 (en) 2006-01-04 2011-05-27 Sederma Sa COSMETIC COMPOSITION CONTAINING GLAUCIN AND USE THEREOF
WO2007110415A2 (en) 2006-03-27 2007-10-04 Symrise Gmbh & Co. Kg Use of diacetyl trimers and cosmetic or therapeutic formulations containing these compounds
EP2008662B1 (en) 2006-04-07 2012-08-22 Kao Corporation Lipolysis stimulator
DE102006043587A1 (en) 2006-09-16 2008-03-27 Symrise Gmbh & Co. Kg 2-methyl-2-alkenyl-substituted 1,3-dioxanes as fragrances
EP1923041A1 (en) 2006-10-20 2008-05-21 Symrise GmbH & Co. KG Use of C10-C14 alkane diols for the preparation of a composition for the prophylaxis and/or treatment of Malassezia-induced dandruff, and compositions comprising C10-C14 alkane diols
EP1915982A1 (en) 2006-10-20 2008-04-30 Symrise GmbH & Co. KG Use of 1,2-decanediol for reducing sebum concentration and/or for enhancing penetration of actives into skin areas, and cosmetic and/or dermatological compositions comprising 1,2-decanediol
DE102006050398A1 (en) 2006-10-20 2008-04-24 Henkel Kgaa Cosmetic agent containing purine and / or purine derivative and taurine
EP2025335A1 (en) 2007-08-16 2009-02-18 InterMed Discovery GmbH Extracts with liver-X-receptor modulators, compounds and their use in weight control and treatment of disorders of lipid metabolism
AU2007361007A1 (en) 2007-11-15 2009-05-22 Council Of Scientific And Industrial Research Of India Immunopotentiating composition from labisia pumila extract
WO2009064156A1 (en) 2007-11-15 2009-05-22 Holista Biotechnology Sdn Bhd Novel composition obtained from labisia pumila extract for hepatoprotective activity
MY151834A (en) 2008-03-19 2014-07-14 Government Of Malaysia As Represented By The Ministry Of Science Technology And Innovation Malaysia A standardised aqueous extract of labisia pumila
KR101007252B1 (en) 2008-04-28 2011-01-13 주식회사 엘씨에스바이오텍 a cosmetic composition, a pharmaceutical composition comprising fermented product of extract from labisia pumila
US20130078323A1 (en) 2009-06-16 2013-03-28 Holista Biotech Sdn. Bhd. Adaptogenic activity of labisia pumila extract

Also Published As

Publication number Publication date
WO2013112040A1 (en) 2013-08-01

Similar Documents

Publication Publication Date Title
MX362655B (en) Cosmetic compositions.
MX357554B (en) Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects.
PH12014502512A1 (en) Topical pharmaceutical compositions comprising terbinafine and urea
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
NZ702472A (en) Oil/water-emulsion-type topical compositions containing a retinoid
WO2011149301A3 (en) A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
MY170724A (en) Use of certain trioxygenated benzene derivatives in body fat management
UA104994C2 (en) Sprayable composition containing red vine leaf extract
MX2014014517A (en) Topical compositions in the form of a gel containing a particular solubilised retinoid.
IN2014DN09584A (en)
MX365429B (en) Flavor and fragrance formulation (i).
MX359955B (en) Flavor and fragrance formulation (iii).
MX357704B (en) O/w-emulsion-type topical pharmaceutical compositions containing a retinoid.
WO2012108747A3 (en) Composition and cosmetic composition for treating brain cancer comprising helena root extract
WO2012108744A3 (en) Composition and health functional food for treating brain cancer comprising inula flower extract
CL2017002601A1 (en) Compositions for long-las¬ting moisturizing cosmetic formulation comprising ucuuba butter with high concentration of myristic acid, as well as the use of said formulation for the preparation of a highly moisturizing cosmetic product and kit
WO2012001293A3 (en) Cosmetic composition for the nails and use of an isosorbide derivative
WO2012047007A3 (en) Composition for promoting fingernail or toenail growth
WO2012108743A3 (en) Composition and cosmetic composition for treating brain cancer comprising white pharbitis seed extract
MX2017011425A (en) Cosmetic antioxidant formulation for topical use comprising an association of plant extracts, use thereof.
MX360017B (en) Flavor and fragrance formulation (iv).
MX358798B (en) Flavor and fragrance formulation (v).
MX2015004315A (en) Flavor and fragrance formulation (vi).
WO2013117866A3 (en) Use of an apple tree leaf extract in a cosmetic skin-firming composition
PL402321A1 (en) Hand skincare